Filing Details

Accession Number:
0001140361-12-022879
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-03 17:51:01
Reporting Period:
2012-05-01
Filing Date:
2012-05-03
Accepted Time:
2012-05-03 17:51:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
943819 Resmed Inc RMD Surgical & Medical Instruments & Apparatus (3841) 980152841
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1186102 C Peter Farrell Resmed Inc.
9001 Spectrum Center Boulevard
San Diego CA 92123
Executive Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Resmed Common Stock Acquisiton 2012-05-01 53,535 $10.37 383,811 No 4 M Direct
Resmed Common Stock Disposition 2012-05-01 53,535 $34.02 330,276 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Resmed Common Stock ResMed Common Stock options Disposition 2012-05-01 53,535 $0.00 53,535 $10.37
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,640 2004-12-19 2013-12-19 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Resmed Common Stock 21,391 Indirect Peter C. Farrell July 2010 Annuity Trust
Resmed Common Stock 200,000 Indirect Peter C. Farrell December 2010 Annuity Trust
Resmed Common Stock 200,000 Indirect Peter C. Farrell August 2011 Annuity Trust
Resmed Common Stock 200,000 Indirect Peter C. Farrell December 2011 Annuity Trust
Resmed Common Stock 200,000 Indirect Peter C. Farrell February 2012 Annuity Trust
Footnotes
  1. Represents date options first became exercisable. Options vest 1/4 annually.
  2. This transaction was executed in multiple trades at prices ranging from $33.80 to $34.16. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.